Sodium Iodide → 6-Bromo-2-[2-(4-cyclobutylpiperazin-1-yl)-2-oxoethyl]-1,2,3,4-tetrahydroisoquinoline
反応式
Cl.[Br:2][C:3]1[CH:4]=[C:5]2[C:10](=[CH:11][CH:12]=1)[CH2:9][NH:8][CH2:7][CH2:6]2.Cl[CH:14]1[CH2:19][N:18]([CH:20]2[CH2:23][CH2:22][CH2:21]2)[CH2:17][CH2:16][NH:15]1.[C:24](N)(=[O:26])[CH3:25].C([O-])([O-])=O.[K+].[K+].[Na+].[I-]>C(#N)C.O>[Br:2][C:3]1[CH:4]=[C:5]2[C:10](=[CH:11][CH:12]=1)[CH2:9][N:8]([CH2:25][C:24]([N:15]1[CH2:16][CH2:17][N:18]([CH:20]3[CH2:23][CH2:22][CH2:21]3)[CH2:19][CH2:14]1)=[O:26])[CH2:7][CH2:6]2参加物
7
反応物 4
生成物 1
試薬・触媒・溶媒 2
実験手順
To a stirred solution of 6-bromo-1,2,3,4-tetrahydro-isoquinoline hydrochloride (3.09 g, 12.4 mmol) in acetonitrile (50.0 ml) is added 2-chloro-(4-cyclobutyl-piperazine)-acetamide (2.69 mg, 12.4 mmol, 1.0 eq.), K2CO3 (5.14 g, 37.3 mmol, 3.0 eq.), and NaI (400 mg). The resulting mixture is stirred at rt overnight. Water (40.0 ml) is added to quench the reaction, and then the acetonitrile is evaporated. The residue is extracted with DCM (40 ml×3). The combined organic phase is dried over sodium sulfate, and the solvent is removed under reduced pressure to give a residue that is purified by flash silica gel chromatography (EtOAc/4% TEA) to give the title compound. MS (+VE) m/z 392.2 (M++1).
後処理
- customto quench
- customthe reaction
- customthe acetonitrile is evaporated
- extractionThe residue is extracted with DCM (40 ml×3)
- dry with materialThe combined organic phase is dried over sodium sulfate
- customthe solvent is removed under reduced pressure
- customto give a residue that
- customis purified by flash silica gel chromatography (EtOAc/4% TEA)
出典と根拠
- ORDレコード
- ord-f4e9ceaaaaa54b9a966ecca8ec436657
- 出典データセット
- uspto-grants-2010_09
- 特許番号
- US07795262B2
反応ノート
読み込み中…